Single-Chamber Prefilled Syringes Market Report 2026

Single-Chamber Prefilled Syringes Market Overview

• Single-Chamber Prefilled Syringes market size has reached to $11.97 billion in 2025 • Expected to grow to $25.79 billion in 2030 at a compound annual growth rate (CAGR) of 16.7% • Growth Driver: Rising Prevalence Of Chronic Diseases Fuels Single-Chamber Prefilled Syringes Market Growth • Market Trend: Innovation In Polymer Syringe Systems To Enhance Safety And Drug Stability • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Single-Chamber Prefilled Syringes Market?

Single-chamber prefilled syringes refer to syringes that come pre-filled with a specific dose of medication in a single compartment. These syringes are designed for easy, precise administration, reducing the risk of dosing errors and improving convenience for both healthcare providers and patients. The main types of products in single-chamber prefilled syringes are glass and plastic. A glass-based single-chamber prefilled syringe is a type of single-chamber prefilled syringe manufactured using glass. Glass is the most preferred material for manufacturing prefilled syringes. A plastic-based single-chamber prefilled syringe uses plastic as the preferred material. These single-chamber prefilled syringes are used for injecting prefilled vaccine products, biological, or pharmaceutical products.

What Is The Single-Chamber Prefilled Syringes Market Growth Forecast?

The single-chamber prefilled syringes market size is expected to see rapid growth in the next few years. It will grow to $25.79 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to increasing demand for self-administered injectables, rising biologics pipeline expansion, growth in home-based drug administration, increasing focus on sustainable packaging solutions, expansion of prefilled syringe adoption in emerging markets. Major trends in the forecast period include increasing adoption of prefilled drug delivery systems, rising demand for ready-to-use injectable formats, growing use of plastic-based syringe materials, expansion of vaccine and biologic packaging applications, enhanced focus on dose accuracy and patient safety.

Global Single-Chamber Prefilled Syringes Market Segmentation

1) By Type: Glass, Plastic 2) By Application: Vaccine Product, Biologic, Pharmaceutical Product 3) By End-User: Hospitals And Clinics, Ambulatory Care Centers And Specialty Clinics, Home Healthcare And Self-Administration Subsegments: 1) By Glass: Borosilicate Glass Syringes, Type I Glass Syringes, Type II Glass Syringes 2) By Plastic: Polypropylene Syringes, Polycarbonate Syringes, Cyclo-olefin Polymer Syringes

What Is The Driver Of The Single-Chamber Prefilled Syringes Market?

The growing prevalence of chronic diseases such as diabetes and cancer is contributing to the growth of the single-chamber prefilled syringe market. Diabetes patients who require insulin therapy when medicines cannot control their blood glucose levels use the single-chamber prefilled syringe. The growing prevalence of chronic diseases such as diabetes and cancer is rising primarily due to increasingly sedentary lifestyles that disrupt metabolic balance and weaken long-term physiological resilience, ultimately elevating the risk of chronic illness. Single-chamber prefilled syringes help chronic diseases such as diabetes and cancer by enabling fast, accurate, and convenient delivery of injectable therapies, improving treatment adherence and reducing dosing errors during long-term care. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency responsible for international public health, by 2050, over 35 million new cancer cases are projected, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the growing prevalence of chronic diseases such as diabetes and cancer drives the market for single-chamber prefilled syringes.

Key Players In The Global Single-Chamber Prefilled Syringes Market

Major companies operating in the single-chamber prefilled syringes market are Becton Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, Weigao Group Medical Polymer Company Limited, Stevanato Group S.p.A., Baxter International Inc., Vetter Pharma International GmbH, Terumo Corporation, Ypsomed Holding AG, SHL Medical AG, Ompi, Elcam Medical A.C.S. Ltd., Oval Medical Technologies Ltd., West Pharmaceutical Services Inc., Gerresheimer Regensburg GmbH, SCHOTT North America Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Aptar Pharma Services Inc., Bespak Europe Ltd., Credence MedSystems Inc., Datwyler Pharma Packaging International Holding AG, Dätwyler Sealing Solutions AG, Fresenius Kabi AG, Haselmeier GmbH, Hikma Pharmaceuticals PLC, HTL-STREFA S.A., Intas Pharmaceuticals Ltd.

Global Single-Chamber Prefilled Syringes Market Trends and Insights

Major companies operating in the Single-Chamber Prefilled Syringes market are focusing on developing innovative polymer-based single-dose prefilled syringe systems, to meet the rising demand for scalable, cost-effective, and safe injectable delivery formats driven by increasing biologics use and home self-administration. polymer prefilled syringes are made using materials like cyclic-olefin polymer (COP) or cyclic-olefin copolymer (COC), combining excellent drug stability and inertness with lower risk of breakage compared to traditional glass syringes. For instance, in January 2023, Sharps Technology, Inc., a U.S.-based medical device and pharmaceutical-packaging company, announced it would introduce next-generation specialty polymer prefillable syringe systems manufactured in cooperation with Nephron Pharmaceuticals using COP and COC materials. These advanced syringes are designed to reduce contamination, minimize dead space, and eliminate breakage risk, while maintaining compatibility with existing fill-finish lines, and they are also free from silicon to reduce aggregation risk making them safer and more reliable. Source: Sharps Technology press release.

What Are Latest Mergers And Acquisitions In The Single-Chamber Prefilled Syringes Market?

In October 2024, Becton, Dickinson and Company, a US-based healthcare technology company, partnered with Ypsomed Holding AG for an undisclosed amount. With this partnership, Becton, Dickinson and Company aim to advance self-injection solutions for high-viscosity biologic drugs by integrating BD’s Neopak XtraFlow glass prefillable syringe with Ypsomed’s YpsoMate 2.25 autoinjector to de-risk combination product development, accelerate time-to-market, and improve patient usability for next-generation biologics. Ypsomed Holding AG is a Switzerland-based technology company that specializes in designing and manufacturing autoinjectors and drug-delivery platforms for subcutaneous therapies.

Regional Outlook

North America was the largest region in the single-chamber prefilled syringes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Single-Chamber Prefilled Syringes Market?

The single-chamber prefilled syringes market consists of sales of glass and plastic single-chamber prefilled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.